器官移植受者难治性慢性鼻窦炎的危险因素
该回顾性队列研究纳入2017至2022年在梅奥诊所就诊的925例移植受者,其中549例符合纳入标准并分为需内镜鼻窦手术组与药物治疗成功组。201/549(37%)为药物难治需手术,移植前复发性急性鼻窦炎与难治性疾病风险升高相关(OR 8.68,95%CI 3.72-20.28,p<0.0001)。
要点
- 549例移植受者中201/549(37%)需内镜鼻窦手术,348/549(63%)药物治疗成功。
- 移植前复发性急性鼻窦炎患者发生难治性疾病的可能性为8.68倍(95%CI 3.72-20.28,p<0.0001)。
- 移植后慢性鼻窦炎伴鼻息肉、牙源性慢性鼻窦炎和非侵袭性真菌性鼻窦炎是治疗失败的主要决定因素。
核心结论
- 该预测模型可高准确度识别器官移植人群中可能发生难治性慢性鼻窦炎的患者。
研究设计与样本
- 回顾性队列研究,回顾性病历审查2017至2022年在梅奥诊所就诊的925例移植受者,549例符合纳入标准并分为需内镜鼻窦手术组与药物治疗成功组,进行单因素分析和逻辑回归分析。
主要发现
- 549例中201/549(37%)为药物难治需内镜鼻窦手术,348/549(63%)药物治疗成功。
- 移植前复发性急性鼻窦炎患者发生难治性疾病的可能性为8.68倍(95%CI 3.72-20.28,p<0.0001)。
- 移植后药物治疗失败的最大决定因素包括慢性鼻窦炎伴鼻息肉、牙源性慢性鼻窦炎和非侵袭性真菌性鼻窦炎。
- 中性粒细胞减少、再生障碍性贫血和活体移植也与需内镜鼻窦手术的难治性慢性鼻窦炎相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Studies suggest that transplant patients are at risk for chronic rhinosinusitis (CRS). However, there is limited information in the literature regarding frequency and reasons for failure of adequate medical therapy. We aim to determine the risk factors associated with the development of medically recalcitrant CRS requiring endoscopic sinus surgery (ESS). STUDY DESIGN: Retrospective cohort. SETTING: Mayo Clinic. METHODS: This is a retrospective chart review of 925 transplant recipients seen at Mayo Clinic between 2017 and 2022. INCLUSION CRITERIA: (1) a rhinologic consultation after transplant and (2) clinical diagnosis of CRS. A total of 549 patients met the inclusion criteria and were divided based on the need for ESS versus successful treatment with medical therapy. Univariate and logistic regression analyses were performed to identify risk factors and predictive variables related to failure of medical therapy. RESULTS: Of the 549 patients, 201/549 (37%) had medically recalcitrant disease requiring ESS, while 348/549 (63%) were successfully treated with medical therapy Based on logistic regression, patients with recurrent acute rhinosinusitis in the pretransplant period were 8.68 more likely to have a recalcitrant disease (95% confidence interval, 3.72-20.28, p < 0.0001). Some of the largest determinants of medical therapy failure in the posttransplant period were CRS with nasal polyps, odontogenic CRS, and noninvasive fungal sinusitis. The presence of neutropenia, aplastic anemia, and living transplant were also associated with medically recalcitrant CRS requiring ESS. CONCLUSION: Our predictive model identifies with high accuracy the patients who may be at risk of developing recalcitrant CRS in the organ transplant population.
引用
- Candelo E, Avila-Castano K, Verez A, et al. Risk Factors for Recalcitrant Chronic Rhinosinusitis in Organ Transplant Recipients. Otolaryngol Head Neck Surg. 2023. PMID: 36939492. doi:10.1002/ohn.236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。